CAS 1693758-51-8

Eganelisib

CAS: 1693758-51-8

Formel: C₃₀H₂₄N₈O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 528.5640

Ref: IN-DA00ASDC

Eganelisib

CAS: 1693758-51-8

Eganelisib

Formel: C₃₀H₂₄N₈O₂

Reinheit: ≥98%

Molekulargewicht: 528.56

Ref: 54-BUP10266

IPI-549

CAS: 1693758-51-8

IPI-549

Formel: C₃₀H₂₄N₈O₂

Reinheit: 98%

Molekulargewicht: 528.56395

Ref: 54-BISN0153

Eganelisib

CAS: 1693758-51-8

(S)-2-Amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

Formel: C₃₀H₂₄N₈O₂

Reinheit: 98%

Molekulargewicht: 528.56

Ref: IN-DG755983

Eganelisib

CAS: 1693758-51-8

Eganelisib (IPI-549) is an inhibitor of PI3Kγ (IC50 = 16, 3,200, 3,500, and >8,400 nM for PI3Kγ, PI3Kα, PI3Kβ, and PI3Kδ, respectively)

Formel: C₃₀H₂₄N₈O₂

Reinheit: 98.92% - 99.28%

Farbe und Form: Solid

Molekulargewicht: 528.56

Ref: TM-T5432

IPI 549-d5

Kontrolliertes Produkt

CAS: 1693758-51-8

Formel: C₃₀D₅H₁₉N₈O₂

Farbe und Form: Neat

Molekulargewicht: 533.595

Ref: TR-I739412

IPI 549-d5

CAS: 1693758-51-8

IPI 549-d5 is a small molecule inhibitor of PI3K-γ that has been shown to have anti-tumor activity in vitro and in vivo. IPI 549-d5 inhibits tumor growth by targeting the m2 phenotype, which is associated with immune cells and is found in high levels in cancerous tumors. IPI 549-d5 was also shown to inhibit autoimmune diseases by blocking the PI3K-γ pathway, which regulates T cell activation.

Formel: C₃₀H₁₉D₅N₈O₂

Reinheit: Min. 95%

Molekulargewicht: 533.59 g/mol

Ref: 3D-TSC75851